Search

Your search keyword '"Pesenti Gritti A"' showing total 115 results

Search Constraints

Start Over You searched for: Author "Pesenti Gritti A" Remove constraint Author: "Pesenti Gritti A"
115 results on '"Pesenti Gritti A"'

Search Results

1. Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

2. Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer

9. A General Population Twin Study of the CBCL/6-18 DSM-Oriented Scales

14. Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer

15. A genetically informed study of the association between childhood separation anxiety, sensitivity to CO(sub 2), panic disorder, and the effect of childhood parental loss

17. Human iPSC-based neurodevelopmental models of globoid cell leukodystrophy uncover patient- and cell type-specific disease phenotypes

20. Unstable maternal environment, separation anxiety, and heightened CO2 sensitivity induced by gene-by-environment interplay.

21. Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

24. Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer

25. Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

28. CoSMed: A Confidentiality-Verified Social Media Platform

32. Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

34. Psychometric Properties of the Social Phobia and Anxiety Inventory for Children (SPAI-C)

35. Gene-environment interactions in panic disorder and CO2 sensitivity: Effects of events occurring early in life

37. [The ciliopathies--Polycystic Kidney Disease]

40. Unstable maternal environment, separation anxiety, and heightened CO2 sensitivity induced by gene-by-environment interplay

49. Genetic Study of the Acute Anxious Response to Carbon Dioxide Stimulation in Man

50. Gene-Environment Interactions in Panic Disorder and CO₂ Sensitivity: Effects of Events Occurring Early in Life

Catalog

Books, media, physical & digital resources